|
1
|
Henle F, Fischer C, Meyer DK and Leemhuis
J: Vasoactive intestinal peptide and PACAP38 control
N-methyl-D-aspartic acid-induced dendrite motility by modifying the
activities of Rho GTPases and phosphatidylinositol 3-kinases. J
Biol Chem. 281:24955–24969. 2006. View Article : Google Scholar
|
|
2
|
Kimura H, Kawatani M, Ito E and Ishikawa
K: PACAP facilitate the nerve regeneration factors in the facial
nerve injury. Regul Pept. 123:135–138. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
May V, Lutz E, MacKenzie C, Schutz KC,
Dozark K and Braas KM: Pituitary adenylate cyclase-activating
polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates
multiple neurotrophic signaling pathways: Akt activation through
phosphatidylinositol 3-kinase gamma and vesicle endocytosis for
neuronal survival. J Biol Chem. 285:9749–9761. 2010. View Article : Google Scholar
|
|
4
|
Bourgault S, Vaudry D, Botia B, et al:
Novel stable PACAP analogs with potent activity towards the PAC1
receptor. Peptides. 29:919–932. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmidt DT, Rühlmann E, Waldeck B, et al:
The effect of the vasoactive intestinal polypeptide agonist Ro
25–1553 on induced tone in isolated human airways and pulmonary
artery. Naunyn Schmiedebergs Arch Pharmacol. 364:314–320. 2001.
|
|
6
|
Deutsch PJ and Sun Y: The 38-amino acid
form of pituitary adenylate cyclase-activating polypeptide
stimulates dual signaling cascades in PC12 cells and promotes
neurite outgrowth. J Biol Chem. 267:5108–5113. 1992.
|
|
7
|
Deutsch PJ, Schadlow VC and Barzilai N:
38-Amino acid form of pituitary adenylate cyclase activating
peptide induces process outgrowth in human neuroblastoma cells. J
Neurosci Res. 35:312–320. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rawlings SR: PACAP, PACAP receptors, and
intracellular signalling. Mol Cell Endocrinol. 101:C5–C9. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fukiage C, Nakajima T, Takayama Y,
Minagawa Y, Shearer TR and Azuma M: PACAP induces neurite outgrowth
in cultured trigeminal ganglion cells and recovery of corneal
sensitivity after flap surgery in rabbits. Am J Ophthalmol.
143:255–262. 2007. View Article : Google Scholar
|
|
10
|
Klabunde T and Hessler G: Drug design
strategies for targeting G-protein-coupled receptors. Chembiochem.
3:928–944. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun C, Song D, Davis-Taber RA, et al:
Solution structure and mutational analysis of pituitary adenylate
cyclase-activating polypeptide binding to the extracellular domain
of PAC1-RS. Proc Natl Acad Sci USA. 104:7875–7880. 2007. View Article : Google Scholar
|
|
12
|
Kumar S, Pioszak A, Zhang C, Swaminathan K
and Xu HE: Crystal structure of the PAC1R extracellular domain
unifies a consensus fold for hormone recognition by class B
G-protein coupled receptors. PLoS One. 6:e196822011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beebe X, Darczak D, Davis-Taber RA, et al:
Discovery and SAR of hydrazide antagonists of the pituitary
adenylate cyclase-activating polypeptide (PACAP) receptor type 1
(PAC1-R). Bioorg Med Chem Lett. 18:2162–2166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilkins MR, Gasteiger E, Bairoch A, et al:
Protein identification and analysis tools in the ExPASy server.
Methods Mol Biol. 112:531–552. 1999.PubMed/NCBI
|
|
15
|
Dautzenberg FM, Mevenkamp G, Wille S and
Hauger RL: N-terminal splice variants of the type I PACAP receptor:
isolation, characterization and ligand binding/selectivity
determinants. J Neuroendocrinol. 11:941–949. 1999. View Article : Google Scholar
|
|
16
|
Kufareva I, Rueda M, Katritch V, Stevens
RC and Abagyan R; GPCP Dock 2010 participants. Status of GPCR
modeling and docking as reflected by community-wide GPCR Dock 2010
assessment. Structure. 19:1108–1126. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Yang HQ, Li J and Fang HS:
Homology modeling of three-dimensional structure of human CCR5.
Pharmaceutical Biotechnology. 19:432–436. 2012.(In Chinese).
|
|
18
|
Lin KJ, Zhu DJ, Leng YG and You QD:
Structural characterization of human parathyroid hormone 1
receptor. Acta Phys Chim Sin. 28:1783–1789. 2012.
|
|
19
|
Mirzadegan T, Benkö G, Filipek S and
Palczewski K: Sequence analyses of G-protein-coupled receptors:
similarities to rhodopsin. Biochemistry. 42:2759–2767. 2003.
View Article : Google Scholar
|
|
20
|
Bowie JU, Lüthy R and Eisenberg D: A
method to identify protein sequences that fold into a known
three-dimensional structure. Science. 253:164–170. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seaborn T, Masmoudi-Kouli O, Fournier A,
Vaudry H and Vaudry D: Protective effects of pituitary adenylate
cyclase-activating polypeptide (PACAP) against apoptosis. Curr
Pharm Des. 17:204–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fila T, Trazzi S, Crochemore C, Bartesaghi
R and Ciani E: Lot1 is a key element of the pituitary adenylate
cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that
negatively regulates neuronal precursor proliferation. J Biol Chem.
284:15325–15338. 2009. View Article : Google Scholar
|
|
23
|
Deguil J, Jailloux D, Page G, et al:
Neuroprotective effects of pituitary adenylate cyclase-activating
polypeptide (PACAP) in MPP+-induced alteration of
translational control in Neuro-2a neuroblastoma cells. J Neurosci
Res. 85:2017–2025. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Somogyvári-Vigh A and Reglodi D: Pituitary
adenylate cyclase activating polypeptide: a potential
neuroprotective peptide. Curr Pharm Des. 10:2861–2889.
2004.PubMed/NCBI
|
|
25
|
Hruby VJ: Designing peptide receptor
agonists and antagonists. Nat Rev Drug Discov. 1:847–858. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Palczewski K, Kumasaka T, Hori T, et al:
Crystal structure of rhodopsin: a G protein-coupled receptor.
Science. 289:739–745. 2000. View Article : Google Scholar
|
|
27
|
Elbegdorj O, Westkaemper RB and Zhang Y: A
homology modeling study toward the understanding of
three-dimensional structure and putative pharmacological profile of
the G-protein coupled receptor GPR55. J Mol Graph Model. 39:50–60.
2013. View Article : Google Scholar
|
|
28
|
Okada T, Sugihara M, Bondar AN, Elstner M,
Entel P and Buss V: The retinal conformation and its environment in
rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol.
342:571–583. 2004. View Article : Google Scholar
|
|
29
|
Tibaduiza EC, Chen C and Beinborn M: A
small molecule ligand of the glucagon-like peptide 1 receptor
targets its amino-terminal hormone binding domain. J Biol Chem.
276:37787–37793. 2001.PubMed/NCBI
|
